Chadi Hage Chehade
@chadihcmd
Followers
352
Following
931
Media
29
Statuses
379
Post-Doctoral Research Fellow @Huntsmancancer 🇺🇸 | GU Oncology @UUtah MD 23' @usjliban 🇱🇧🇫🇷
Salt Lake City, Utah
Joined August 2023
RT @PGrivasMDPhD: So honored to receive this prestigious award by @eaonc kudos to all investigators/staff who work hard to conduct trials….
0
20
0
RT @HemOncToday: The majority of patients with the most common advanced or metastatic #cancers in the United States do not undergo next-gen….
0
3
0
RT @urotoday: Real-world treatment delays between lutetium-177 and cabazitaxel in advanced #ProstateCancer. @YeonjungJoHCI & @umangtalking….
0
4
0
RT @DanaFarber_GU: GU Research Digest for the week of June 14 - 20: a selection of publications about GU cancers in high-impact journals. S….
0
10
0
RT @APCCC_Lugano: Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Pr….
0
16
0
Excited to see our work published in @CCR_AACR ! Real-world pts w/ mHSPC #prostatecancer w/ HRRalt had worse survival than those w/ non-altered HRR 👉�.Grateful for terrific support from team @RyonGraf @umangtalking @neerajaiims @urotoday @OncoAlert
Just in @CCR_AACR 👉Congrats @chadihcmd @umangtalking & @Huntsman_GU team👉Poor outcomes w/ SOC Rx in mHSPC #prostatecancer w/HRRm in 637 real-world US pts👇 @flatironhealth @FoundationATCG @RyonGraf 👉 need to add PARPi 👉free link: @OncoAlert @urotoday
9
23
72
RT @huntsmancancer: Our researchers made a strong showing at #ASCO25 —sharing bold ideas, breakthrough science, and real-world insights to….
0
4
0
RT @ReginaBarCar: Adjuvant Nivolumab in MIUC – Real-World Data with a Focus on Disparities led by @arafflemd .A quick tweetorial 🧵. ⁉️ Can….
0
31
0
RT @neerajaiims: Stellar presentation @ASCO #ASCO25 by trailblazer @DrRanaMcKay on ETCTN trial with radium +|- olaparib in mCRPC #prostatec….
0
22
0
RT @TiansterZhang: Great poster session this morning with @nsayeghmd highlighting work in #prostatecancer TMB & MSI-H w/ real world IO outc….
0
12
0
RT @nsayeghmd: 👉🏻 Superstar @ziremozay presenting @ASCO our real-world data showing lutetium has better survival outcomes than cabazitaxel….
0
24
0
RT @ziremozay: 🌟Great poster presentation by @nsayeghmd at #ASCO25!. Real-world pts with mCRPC👉TMB-H (without MSI-H) & MSI-H have similar o….
0
17
0
RT @shilpaonc: #ASCO2025 Powerful letter from @ASCO #DailyNews Editor @neerajaiims .“In the fight against cancer, we are united by purpose.….
0
23
0
RT @fumikochino: "Utilization and timing of first tumor next-generation sequencing testing in patients with five most common cancers in the….
0
5
0
RT @ziremozay: 🌟Great presentation by @chadihcmd at #ASCO25!!. Utilization and timing of NGS in pts w/ 5 most common cancers in the US👉Many….
0
20
0
RT @nsayeghmd: 👉🏻 Our very own @chadihcmd presenting @ASCO a real-world study showing most patients do not undergo NGS testing, and a subst….
0
14
0
RT @MarcMachaalani: Fantastic presentation by @ReneeSaliby discussing our work evaluating MAdCAM-1, a circulating surrogate of gut dysbiosi….
0
15
0